Free Trial

Alnylam Pharmaceuticals (ALNY) Insider Trading & Ownership

Alnylam Pharmaceuticals logo
$294.41 +9.57 (+3.36%)
As of 11:10 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Alnylam Pharmaceuticals (NASDAQ:ALNY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.86%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$96.14M
Get ALNY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alnylam Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALNY Insider Buying and Selling by Quarter

Alnylam Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/6/2026Sell2,286$330.42$755,340.12  
4/2/2026Sell1,624$319.59$519,014.16  
3/3/2026Sell1,652$319.73$528,193.96  
3/3/2026Sell1,775$319.74$567,538.50  
3/2/2026Sell2,206$327.65$722,795.90  
3/2/2026Sell1,598$327.65$523,584.70  
3/2/2026Sell1,717$327.66$562,592.22  
3/2/2026Sell1,598$327.65$523,584.70  
3/2/2026Sell6,799$327.65$2,227,692.35  
2/17/2026Sell2,041$331.96$677,530.36  
2/13/2026Sell2,242$310.08$695,199.36  
2/13/2026Sell1,959$310.08$607,446.72  
2/13/2026Sell2,242$310.08$695,199.36  
2/13/2026Sell1,959$310.08$607,446.72  
2/13/2026Sell6,958$310.08$2,157,536.64  
1/13/2026Sell2,290$370.33$848,055.70  
1/12/2026Sell2,780$362.87$1,008,778.60  
1/12/2026Sell1,510$362.87$547,933.70  
1/12/2026Sell1,510$362.87$547,933.70  
1/12/2026Sell1,510$362.87$547,933.70  
1/12/2026Sell9,577$362.86$3,475,110.22  
11/17/2025Sell12,128$452.18$5,484,039.04  
11/13/2025Sell10,000$451.27$4,512,700.00  
11/12/2025Sell15,650$453.69$7,100,248.50  
10/3/2025Sell3,022$451.48$1,364,372.56  
10/2/2025Sell3,821$452.05$1,727,283.05  
10/2/2025Sell2,441$452.05$1,103,454.05  
10/2/2025Sell2,937$452.05$1,327,670.85  
10/2/2025Sell1,405$452.05$635,130.25  
10/2/2025Sell8,924$452.05$4,034,094.20  
9/9/2025Sell18,000$467.60$8,416,800.00  
8/19/2025Sell1,455$458.41$666,986.55  
8/18/2025Sell2,274$453.27$1,030,735.98  
8/18/2025Sell1,396$453.27$632,764.92  
8/18/2025Sell11,250$450.00$5,062,500.00  
8/18/2025Sell1,396$453.27$632,764.92  
8/18/2025Sell1,396$453.27$632,764.92  
8/18/2025Sell6,979$453.27$3,163,371.33  
8/14/2025Sell31,448$436.58$13,729,567.84  
6/2/2025Sell19,297$306.00$5,904,882.00  
5/30/2025Sell31,640$304.39$9,630,899.60  
(Data available from 1/1/2013 forward)

ALNY Insider Trading Activity - Frequently Asked Questions

0.86% of Alnylam Pharmaceuticals stock is owned by insiders. Learn more on ALNY's insider holdings.

The following insiders have sold ALNY shares in the last 24 months: Amy W Schulman ($3,224,620.00), Colleen F Reitan ($8,416,800.00), David E I Pyott ($7,161,390.50), Dennis A Ausiello ($19,035,067.84), Jeffrey V Poulton ($5,802,297.28), Kevin Joseph Fitzgerald ($11,761,179.80), Melissa Mclaughlin ($1,274,354.28), Michael W Bonney ($5,062,500.00), Phillip A. Sharp ($3,093,750.00), Pushkal Garg ($23,489,356.52), Tolga Tanguler ($3,315,549.91), and Yvonne Greenstreet ($55,884,601.66).

Insiders have sold a total of 450,896 Alnylam Pharmaceuticals shares in the last 24 months for a total of $147,521,467.79 sold.

Jefferson Shreve (R-IN) has sold shares of Alnylam Pharmaceuticals in the last year totaling $32,500.



This page (NASDAQ:ALNY) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners